InhA — Drug Target

All drugs that target InhA — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

Antitubercular · Antitubercular agent

Phase 3 pipeline (2)

• Tuberculosis treatment · National Institute of Allergy and Infectious Diseases (NIAID) · Antitubercular · Infectious Disease
  Isoniazid works by inhibiting the synthesis of mycolic acid in Mycobacterium tuberculosis, thereby inhibiting bacterial growth and replication.
• isoniazid , randomized, open label · National Taiwan University Hospital · Antitubercular agent · Infectious disease
  Isoniazid inhibits the synthesis of mycolic acid in Mycobacterium tuberculosis by inhibiting the enzyme enoyl-acyl carrier protein reductase (InhA).